The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identifying Interactions that Determine Fragment Binding at Protein Hotspots.EBI
Cambridge Crystallographic Data Centre
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.EBI
Birla Institute of Technology
Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.EBI
University College of Pharmaceutical Sciences
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.EBI
Birla Institute of Technology
Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.EBI
Soochow University
Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.EBI
Birla Institute of Technology
ATP-binding site of bacterial enzymes as a target for antibacterial drug design.EBI
University of Ljubljana
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.EBI
University of Illinois At Chicago
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.EBI
Peking Union Medical College
Comprehensive coverage on anti-mycobacterial endeavour reported during 2022.EBI
L. M. College of Pharmacy
Emerging impact of triazoles as anti-tubercular agent.EBI
Barauni (A Constituent Unit of Lalit Narayan Mithila University)
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.EBI
Birla Institute of Technology & Science-Pilani
Triazole derivatives and their anti-tubercular activity.EBI
Wuhan University of Science and Technology
Recent advances of pyrazole-containing derivatives as anti-tubercular agents.EBI
Wuhan University of Science and Technology
Substituted pyrrolo[2,3-b]pyridines as MLK inhibitorsBDB
The University of Rochester
3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists. Part 2.BDB
Gnf
Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro.BDB
Janssen Research Foundation